aamc.org does not support this web browser.

Advocacy & Policy

Advocacy & Policy

Two-page fact sheet detailing how J-1 and H-1B visa holders serve as an important complement within the health workforce, helping to fill gaps in the shortage.

  • PDF
Biomedical Research

Explore NIH grant funding data, including funding trends, funding by IC, new and competing awards, and multiyear funding, updated throughout the fiscal year.

Advocacy & Policy

A resource outlining Trump administration executive actions most likely to impact academic medicine.

About Our Advocacy

The AAMC works with policymakers and other leaders to advance policy priorities that strengthen the nation’s health and well-being.

Learn more about how the AAMC advocates on behalf of academic medicine.

Learn About Our Advocacy

Our Legislative and Policy Priorities

People with raised fists at a demonstration in the city

AAMC Action – Let’s Raise Our Voices Together

AAMC Action is a community of students, residents, researchers, faculty members, physicians, and others who advocate on behalf of academic medicine to improve the health of people everywhere.

Join Us

Find Advocacy & Policy Content

  • Recent
  • Relevance
111 - 115 of 3794 results No filters applied
Testimony & Correspondence

AAMC joins 259 organizations in support of $500 million for AHRQ in FY27.

  • March 2, 2026
  • PDF
Testimony & Correspondence

The AAMC endorses the reintroduction of the Senate Foreign Medical School Accountability Fairness Act (S.3757).

  • March 2, 2026
  • PDF
Washington Highlights

HRSA extended the comment deadline on the 340B rebate model RFI and seeks information on the burden associated with reporting 340B data for rebate models.

  • Feb. 27, 2026
Washington Highlights

The House Ways and Means Health Subcommittee held a Feb. 24 hearing on policies to strengthen the workforce and improve patient access nationwide.

  • Feb. 27, 2026
Washington Highlights

The AAMC submitted comments on two new drug payment models aimed at aligning Medicare Part B and D drug prices with economically comparable countries. 

  • Feb. 27, 2026
Capitol building, Washington, DC

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting academic medicine.

Subscribe to receive weekly Hill and regulatory updates to your inbox.

Subscribe